COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to… Jul 5, 2021
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space Jun 30, 2021
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb… Jun 28, 2021
Delic Holdings Inc. Announces Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers… Jun 25, 2021
MYND Life Sciences Working On Truly Novel Research For Depressive And Neurological Diseases Jun 24, 2021
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other… Jun 24, 2021
Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004 Jun 24, 2021
